Samples may be obtained from deceased infants and children in cases of sudden unexpected death in infancy and childhood (SUDIC), in line with national protocols. This practice may take place in Accident and Emergency departments and other areas of a hospital, for example in special care baby units and paediatric wards.

This policy describes the consent and licensing requirements under the Human Tissue Act (HT Act) for removal of relevant material from the deceased, in these cases.

This page provides a summary of the key pieces of legislation, licensing frameworks, and a brief overview of responsibilities for Designated Individuals (DIs), Named Contacts (ODT sector only), Persons Designated (PDs) and Licence Holders.

Information for Designated Individuals (DIs) and named contacts to understand their role and responsibilities.

With the interests of the public and those we regulate at the centre of our work, we aim to maintain confidence by ensuring that human tissue is used safely and ethically, and with proper consent. We regulate organisations that remove, store and use tissue for research, medical treatment, post-mortem examination, teaching and display in public. We also give approval for organ and bone marrow donations from living people.